These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31101242)

  • 1. Fecal Calprotectin, Gut Inflammation and Spondyloarthritis.
    Simioni J; Skare TL; Campos APB; Kotze L; Messias-Reason I; Ioshii SO; Nisihara R
    Arch Med Res; 2019 Jan; 50(1):41-46. PubMed ID: 31101242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
    Campos JF; Resende GG; Barbosa AJA; de Carvalho SC; Lage JA; Cunha PFS; de Souza SCS; Ferrari MLA
    Int J Rheum Dis; 2022 Sep; 25(9):1078-1086. PubMed ID: 35855677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
    Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
    Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
    Fauny M; D'Amico F; Bonovas S; Netter P; Danese S; Loeuille D; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Jun; 14(5):688-693. PubMed ID: 31858121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.
    Klingberg E; Magnusson MK; Strid H; Deminger A; Ståhl A; Sundin J; Simrén M; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2019 Nov; 21(1):248. PubMed ID: 31771630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
    Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
    Olofsson T; Lindqvist E; Mogard E; Andréasson K; Marsal J; Geijer M; Kristensen LE; Wallman JK
    Rheumatology (Oxford); 2019 Jul; 58(7):1176-1187. PubMed ID: 30649509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis.
    Østgård RD; Deleuran BW; Dam MY; Hansen IT; Jurik AG; Glerup H
    Scand J Rheumatol; 2018 Jan; 47(1):48-55. PubMed ID: 28649913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
    Cypers H; Varkas G; Beeckman S; Debusschere K; Vogl T; Roth J; Drennan MB; Lavric M; Foell D; Cuvelier CA; De Vos M; Delanghe J; Van den Bosch F; Elewaut D
    Ann Rheum Dis; 2016 Jul; 75(7):1357-62. PubMed ID: 26698844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis.
    Turina MC; Yeremenko N; Paramarta JE; De Rycke L; Baeten D
    Arthritis Res Ther; 2014 Aug; 16(4):413. PubMed ID: 25135077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between faecal calprotectin and inflammation in peripheral joints and entheses in axial spondyloarthritis.
    Kang KY; Park SH; Hong YS
    Scand J Rheumatol; 2020 Sep; 49(5):397-404. PubMed ID: 32657633
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between fecal calprotectin, anti-Saccharomyces cerevisiae antibodies and other markers of disease activity in patients with spondyloarthritis.
    Moreno Martínez MJ; Moreno Ramos MJ; Linares Ferrando LF
    Reumatol Clin (Engl Ed); 2019; 15(6):360-362. PubMed ID: 29398466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis.
    Duran A; Kobak S; Sen N; Aktakka S; Atabay T; Orman M
    Bosn J Basic Med Sci; 2016 Jan; 16(1):71-4. PubMed ID: 26773186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.